Surveillance for Rates of Pertussis Disease Among Persons Birth Through 59 Months of Age Receiving Pentacel or Other Pertussis Vaccines.
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTaP vaccine
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Therapeutic Use
- Sponsors Sanofi; sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 27 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 27 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.